180 Life Sciences Corp. (ATNF) Fundamentals

180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.
SHARE INFORMATION
Market Cap$ 30,744,000
Shares Outstanding24,400,000
Float29,909,300
Percent Float122.58%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.05
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions62
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months486,435
Institutional Holdings Percent18.2%
Institutional Sold Previous 3 Months542,911
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months17,473
Insider Holdings Percent12.2
Insider Sold Previous 3 Months-
Insider Shares Owned4,170,444
TRADING INFO
52 Week High$ 11.75
52 Week Low$ 1.00
52 Week High Change$ -83.46
21 Day Moving Average$ 1.4738
21 Day Extended Moving Average$ 1.4892
50 Day Moving Average$ 2.1068
50 Day Extended Moving Average$ 1.9878
200 Day Moving Average$ 4.0402
200 Day Extended Moving Average$ 3.8614
10 Day Average Volume398,151
20 Day Average Volume752,902
30 Day Average Volume622,937
50 Day Average Volume450,195
Alpha-0.004275
Beta-0.1372
Standard Deviation0.173142
R20.001455
7 Day Price Change$ 0.13
7 Day Percent Change11.5%
21 Day Price Change$ -0.22
21 Day Percent Change-14.86%
30 Day Price Change$ -0.70
30 Day Percent Change-35.71%
Month to Date Price Change$ -0.86
Month to Date Percent Change-40.57%
Quarter to Date Price Change$ -1.33
Quarter to Date Percent Change-51.35%
180 Day Price Change$ -2.39
180 Day Percent Change-65.48%
200 Day Price Change$ -3.81
200 Day Percent Change-75.15%
Year to Date Price Change$ -2.64
Year to Date Percent Change-67.69%

180 Life Sciences Corp. (ATNF) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-3.70
Total Debt To Equity0.10
Int Coverage-108.30
Current Ratio0.60
Leverage Ratio2.80
Quick Ratio0.50
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-1.30
Enterprise Value$ 38,728,175
Price to Sales0.00
Price to Free Cash-3.50
PE High Last 5 Years0.00
Price To Book1.10
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book-3.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-34.38
Return on Equity-58.40
Return on Capital-75.93

180 Life Sciences Corp. (ATNF) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMarcum LLP
CEOJames N. Woody
Emplyoees7
Last AuditUE
CIK0001690080
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address3000 El Camino Real, Bldg. 4
Suite 100
Palo Alto, CA 94306
Websitehttps://www.180lifesciences.com
Facsimile-
Telephone+1 650 507-0669
Email-
Your Recent History
NASDAQ
ATNF
180 Life S..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220519 18:51:20